Ovarian Endometrioma Associated with Very High Serum CA-125 Levels

Chang Gung Medical Journal

Volumn 26, Issue 9, 2003, Pages 695-699

  Shiau, Chii Shinn ^b   Chang, Ming Yang ^b   Chiang, Chi Hsin ^b   Hsieh, Ching Chang ^b   Hsieh, T'Sang T'Ang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

CA 125; Endometrioma

Indexed keywords

CA 125 ANTIGEN; CELL SURFACE PROTEIN;

ADULT; ANTIGEN DETECTION; ARTICLE; CANCER SURGERY; CASE REPORT; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; FEMALE; HUMAN; OVARIAN ENDOMETRIOMA; OVARY CARCINOMA; OVARY TUMOR; PELVIC INFLAMMATORY DISEASE; PREGNANCY; SPONTANEOUS ABORTION; UTERUS MYOMA;

ADULT; CA-125 ANTIGEN; ENDOMETRIOSIS; FEMALE; HUMANS; OVARIAN DISEASES;

EID: 0242596472     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bast RCJ, Feeney M, Lazarus H. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981;68:1331-37.
2. Jacobs I, Bast RCJ. The CA 125 tumor-associated antigen: a review of the literature. Hum Reprod 1989;4:1-12.
3. Ho HN, Wu MY, Chen SU. Total antioxidant status and nitric oxide do not increase in peritoneal fluids from women with endometriosis. Hum Reprod 1997;1:2810-5.
4. Malkasian G Jr, Knapp RC, Lavin PT. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: Discrimination of benign from malignant disease. Am J Obstet Gynecol 1988;159:341-6.
5. Soper JT, Hunter VJ, Daly L. Preoperative serum tumor-associated antigen levels in women with pelvic masses. Obstet Gynecol 1990;75:249-54.
6. Di-Xia C, Schwartz PE, Xinguo L, Zhan Y. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses. Obstet Gynecol 1988;72:23-7.
7. Eltabbakh GH, Belinson JL, Kennedy AW, Gupta M, Webster K, Blumenson LE. Serum CA-125 Measurements > 65 U/mL, Clinical value. J Reprod Med 1997;42:617-24.
8. Masahashi T, Matsuzawa K, Ohsawa M, Narita O, Asai T, Ishihara M. Serum CA 125 levels in patients with endometriosis: Change in CA 125 levels during menstruation. Obstet Gynecol 1988;72:328-31.
9. Pittaway DE, Fayez JA. Serum CA 125 antigen levels increase during menses. Am J Obstet Gynecol 1987;156:75-6.
10. Koninckx PR, Riittinen L, Seppala M, and Cornillie FJ. CA-125 and placental protein 14 concentrations in plasma and peritoneal fluid of women with deeply infiltrating pelvic endometriosis. Fertil Steril 1992b;57:523-30.
11. Kauppila A, Telimaa S, Ronnberg L, Vuori J. Placebo-controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgery. Fertil Steril 1988;49:37-41.
12. Zeimet AG, Marth C, Offner FA. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125. Gynecol Oncol 1996;62:384-9.
13. Johansson J, Santala M, Kauppila A. Explosive rise of serum CA 125 following the rupture of ovarian endometrioma. Hum Reprod 1998;13,3503-4.
14. Check JH, Coate TE, Nowroozi K. Extreme elevation of serum CA 125 in two women with severe endometriosis: case report. Gynecol Endocrinol 1991;5:217-20.